Donor PAI-1 expression inhibits the intimal response of early allograft vascular disease
Authors:
- 1 May 2003
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 22 (5) , 515-518
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferationInternational Journal of Cardiology, 1998
- Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipientsThe American Journal of Medicine, 1998
- Inhibitory Role of Plasminogen Activator Inhibitor-1 in Arterial Wound Healing and Neointima FormationCirculation, 1997
- Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Correlated With the Presence of Transplant Coronary Artery Disease in Cardiac Transplant RecipientsThe American Journal of Cardiology, 1997
- Impaired arterial neointima formation in mice with disruption of the plasminogen gene.Journal of Clinical Investigation, 1997
- Migration of Arterial Wall CellsCirculation Research, 1996
- Vascular Tissue Plasminogen Activator and the Development of Coronary Artery Disease in Heart-Transplant RecipientsNew England Journal of Medicine, 1995
- Role of the plasminogen/plasmin system in thrombosis, hemostasis, restenosis and atherosclerosis evaluation in transgenic animalsTrends in Cardiovascular Medicine, 1995
- HEMOSTATIC CHANGES IN HEART TRANSPLANT RECIPIENTS AND THEIR RELATIONSHIP TO ACCELERATED CORONARY SCLEROSISTransplantation, 1993
- The Role of Plasminogen Activation in Smooth Muscle Cell Migration after Arterial InjuryAnnals of the New York Academy of Sciences, 1992